Skip to main content
. 2017 Jun 29;16:39. doi: 10.1186/s12937-017-0261-6

Table 3.

Dietary intake of participants at baseline and after 4 weeks of the YS, PRE, POST, or CAPSULE treatment perioda,b

BL
(n = 30)
YS
(n = 25)
PRE
(n = 25)
POST
(n = 26)
CAP
(n = 26)
P Value*
Total calories, kcal/d 2472 ± 152 2224 ± 164 2338 ± 161 2092 ± 165 2321 ± 162 0.43
Carbohydrate, g/d 305 ± 21 287 ± 23 291 ± 22 270 ± 23 305 ± 21 0.79
Carbohydrate, % of energy 49.3 ± 1.5 50.5 ± 1.6 50.9 ± 1.6 51.8 ± 1.6 50.6 ± 1.6 0.75
Protein, g/d 97.3 ± 6.7 94.6 ± 7.3 95.8 ± 7.2 84.4 ± 7.3 93.3 ± 7.2 0.67
Protein, % of energy 15.8 ± 0.6 17.0 ± 0.7 16.7 ± 0.7 16.2 ± 0.7 16.0 ± 0.7 0.44
Fat, g/d 96.9 ± 6.1 79.2 ± 6.7 87.0 ± 6.5 75.9 ± 6.7 90.0 ± 6.6 0.09
Fat, % of energy 35.2 ± 1.2 32.9 ± 1.3 33.2 ± 1.3 32.5 ± 1.3 34.4 ± 1.3 0.33
Fiber, g/d 21.3 ± 1.7 21.9 ± 1.8 21.4 ± 1.8 21.0 ± 1.8 24.4 ± 1.8 0.39
Cholesterol, mg/d 310 ± 25 288 ± 27 276 ± 27 283 ± 27.4 262 ± 27 0.71

aValues are means ± SDs; BL, baseline; YS, yogurt smoothie with no BB-12®; PRE, yogurt smoothie with BB-12® added pre-fermentation; POST, yogurt smoothie with BB-12® post-fermentation

bStatistical analyses were calculated using sex, treatment as between subject factor and randomization ID as the within-subject factor and age and BMI as covariates

*P values are for the main effect of treatment